Diffusion of new technology and payment policies: Coronary stents

Health Affairs

Volumn 27, Issue 6, 2008, Pages 1566-1576

  Shih, Chuck ^a   Berliner, Elise ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DROTRECOGIN; PLACEBO; TICLOPIDINE;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ARTICLE; BALLOON CATHETER; BLEEDING; CLINICAL PRACTICE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DIAGNOSIS RELATED GROUP; DRUG APPROVAL; DRUG ELUTING STENT; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; MEDICAL TECHNOLOGY; MEDICARE; NEUTROPENIA; PATIENT SAFETY; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; REIMBURSEMENT; RESTENOSIS; RISK BENEFIT ANALYSIS; SEPSIS; STENT; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME;

DIFFUSION OF INNOVATION; DISCLOSURE; DRUG-ELUTING STENTS; MEDICARE; ORGANIZATIONAL POLICY; REIMBURSEMENT MECHANISMS; UNITED STATES;

EID: 56649095737     PISSN: 02782715     EISSN: 02782715     Source Type: Journal    
DOI: 10.1377/hlthaff.27.6.1566     Document Type: Article

References (35)

1. Centers for Medicare and Medicaid Services, "Medicare Program; Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 1997 Rates; Final Rule," Federal Register 61, no. 170 (1996): 46170.
2. B.G. Firth, "The Disconnect between HCFA and the FDA," Journal of Invasive Cardiology 13, no. 2 (2001): 136-138.
3. H.C. Kung et al., Deaths: Final Data for 2005, National Vital Statistics Reports 56, no. 10 (2008).
4. National Center for Health Statistics, Health: United States, 2007, with Chartbook on Trends in the Health of Americans (Hyattsville, Md.: NCHS, 2007).
5. E.D. Grech, "ABC of Interventional Cardiology: Percutaneous Coronary Intervention, I: History and Development," British Medical Journal 326, no. 7398 (2003): 1080-1082.
6. U. Sigwart et al., "Intravascular Stents to Prevent Occlusion and Restenosis after Transluminal Angioplasty," New England Journal of Medicine 315, no. 12 (1987): 701-706.
7. P.W. Serruys et al., "A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease," New England Journal of Medicine 331, no. 8 (1994): 489-495;
8. and D.L. Fischman et al., "A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease," New England Journal of Medicine 331, no. 8 (1994): 496-501.
9. R. Erbel et al., "Coronary-Artery Stenting Compared with Balloon Angioplasty for Restenosis after Initial Balloon Angioplasty," New England Journal of Medicine 339, no. 23 (1998): 1672-1678.
10. A. Colombo et al., "Intracoronary Stenting without Anticoagulation Accomplished with Intravascular Ultrasound Guidance," Circulation 91, no. 6 (1995): 676-688.
11. C.J. Pepine and D.R. Holmes Jr., "Coronary Artery Stents," Journal of the American College of Cardiology 28, no. 3 (1996): 782-794.
12. D.R. Holmes Jr. et al., "ACC Expert Consensus Document on Coronary Artery Stents: Document of the American College of Cardiology," Journal of the American College of Cardiology 32, no. 5 (1998): 1471-1482.
13. A. Schömig et al., "Coronary Stent Placement in Patients with Acute Myocardial Infarction: Comparison of Clinical and Angiographic Outcome after Randomization to Antiplatelet or Anticoagulant Therapy," Journal of the American College of Cardiology 29, no. 1 (1997): 28-34;
14. and M.B. Leon et al., "Clinical and Angiographic Results from the Stent Anticoagulation Regime Study STARS" (Abstract), Circulation 94 (1996): 4002A.
15. E.M. Rogers, Diffusion of Innovations, 5th ed. (New York: Free Press, 2003).
16. CMS, "Medicare Program: Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 1997 Rates: Final Rule," Federal Register 61, no. 412 (1997): 46166.
17. P.T. Vaitkus, "Economic Impact on Physicians and Hospitals of Proposed Changes in Medicare Reimbursement for Coronary Interventions," American Heart Journal 137, no. 2 (1999): 258-263.
18. Firth, "The Disconnect"
19. D.R. Holmes Jr. et al., "Interventional Cardiology and Intracoronary Stents-A Changing Practice: Approved versus Nonapproved Indications," Catheterization and Cardiovascular Diagnosis 40, no. 2 (1997): 133-138.
20. E.D. Peterson, A.J. Lansky, and K.J. Anstrom, "Evolving Trends in Interventional Device Use and Outcomes: Results from the National Cardiovascular Network Database," American Heart Journal 139,no. 2, Part 1 (2000): 198-207.
21. H. Hashimoto et al., "The Diffusion of Medical Technology, Local Conditions, and Technology Re-Invention: A Comparative Case Study on Coronary Stenting," Health Policy 79, nos. 2-3 (2006): 221-230.
22. CMS, "Medicare Program; Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2003 Rates; Final Rule," Federal Register 67, no. 148 (2002): 50004.
23. S.V. Rao et al., "Patterns and Outcomes of Drug-Eluting Coronary Stent Use in Clinical Practice," American Heart Journal 152, no. 2 (2006): 321-326.
24. "New Stents May Block Income," Modern Healthcare 33, no. 31 (2003): 4.
25. C. Becker, "Stuck in the Middle," Modern Healthcare 32, no. 42 (2002): 4.
26. Rogers, Diffusion of Innovations.
27. J. Patenaude et al., "Evaluation of Clinical Innovation: A Gray Zone in the Ethics of Modern Clinical Practice?" Journal of General Internal Medicine 23, no. 1 Supp. (2007): 27-31.
28. W.L. Biffl et al., "Responsible Development and Application of Surgical Innovations: A Position Statement of the Society of University Surgeons," Journal of the American College of Surgery 206, no. 3 (2008): 1204-1209.
29. Food and Drug Administration and Health Care Financing Administration, "Cardiac Pacemaker Registry," Federal Register 52, no. 141 (1987): 27756-27765.
30. S.B. Foote, Managing the Medical Arms Race: Innovation and Public Policy in the Medical Device Industry (Berkeley: University of California Press, 1992).
31. Food and Drug Administration, "Medical Devices: Revocation of Cardiac Pacemaker Registry," Federal Register 64, no. 226 (1999): 66105-66106.
32. W.H. Maisel et al., "Recalls and Safety Alerts Involving Pacemakers and Implantable Cardioverter-Defibrillator Generators," Journal of the American Medical Association 286, no. 7 (2001): 793-799.
33. W.H. Maisel et al., "Pacemaker and ICD Generator Malfunctions: Analysis of Food and Drug Administration Annual Reports," Journal of the American Medical Association 295, no. 16 (2006): 1901-1906.
34. Medicare Payment Advisory Commission, Payment Basics: Hospital Acute Inpatient Services Payment System (Washington: MedPAC, September 2006).
35. R.P. Dellinger et al., "Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008," Journal of Intensive Care Medicine 34, no. 1 (2008): 17-60.